• 

  'Say No to Drugs' vehicles on round in Surat to spread the message

  News | January 27, 2021 17:00 IST

  Cars and bikes rally was organised in Gujarat's Surat to spread awareness on drug abuse on January 26. The campaign enlightened the youth about the devastating impact of drug use which remains a pressing issue in the country. Rally aimed city's youths to realise the potential threats of drugs consumption and the subsequent damage it causes to one's health.

• 

  New drug inhibits growth of cancer cells

  News | December 24, 2020 18:43 IST

  A recent study has found a newly developed compound that starves cancer cells by attacking their "power plants"

• 

  Drugs case: Arjun Rampal summoned by NCB on Wednesday

  Celebrities | December 15, 2020 15:48 IST

  The NCB has summoned Bollywood actor Arjun Rampal on Wednesday for questioning in a drugs case.

• 

  DRI seizes 504 grams of cocaine concealed in steam press iron

  India | November 19, 2020 17:27 IST

  The Directorate of Revenue Intelligence on Thursday busted an international racket of drug smuggling. 

• 

  Coronavirus antibody drug study paused over safety concerns

  Science | October 30, 2020 23:20 IST

  A study testing an experimental antibody drug for the coronavirus has been paused to investigate a possible safety issue.

• 

  Alembic Pharma JV gets USFDA nod for antifungal topical solution

  World | October 22, 2020 12:49 IST

  Drug firm Alembic Pharmaceuticals on Thursday said its joint venture firm Aleor Dermaceuticals has received final approval from the US health regulator for anti-fungal Tavaborole Topical Solution.

• 

  Alembic Pharma gets USFDA nod for cholesterol lowering drug

  Business | October 21, 2020 12:09 IST

  Drug firm Alembic Pharma on Wednesday said it has received approval from the US health regulator for Fenofibrate capsules, which reduces cholesterol and triglycerides in blood.

• 

  Watch: Akshay Kumar opens up on Sushant, drug use in Bollywood

  Entertainment | October 03, 2020 22:02 IST

  Ever since the death of actor Sushant Singh Rajput, the Hindi film industry has come under spotlight over the issue of drug use with big names like Deepika Padukone, Shraddha Kapoor, Sara Ali Khan and others being probed in connection with the death

• 

  Politician files complaint against Karan Johar, Deepika, Vicky and others over alleged 'drug party'

  Celebrities | September 16, 2020 16:56 IST

  Shiromani Akali Dal (SAD) leader Manjinder Singh Sirsa filed a fresh complaint to the NCB over the alleged 'drug party' hosted by Karan Johar. The party came to the limelight a year back and was attended by Bollywood biggies including Deepika Padukone, Malaika Arora, Arjun Kapoor, Shahid Kapoor, Vicky Kaushal, Varun Dhawan and others.

• 

  Athawale backs Ravi Kishan on Jaya Bachchan's 'defaming film industry' remark in RS

  News | September 15, 2020 19:57 IST

  Minister of State for Social Justice and Empowerment Ramdas Athawale on September 15 reacted on Samajwadi Party Rajya Sabha MP Jaya Bachchan's speech in which she slammed BJP RS MP and Bollywood actor Ravi Kishan.

• 

  France to impose on-the-spot fines against drug use

  World | July 26, 2020 17:55 IST

  French authorities will introduce on-the-spot fines nationwide for drug users, particularly targeting cannabis, from September, Prime Minister Jean Castex announced.

Advertisement
• 

  Several drugs under trial for COVID-19, remdesivir leading contender: Scientists

  Science | May 23, 2020 15:55 IST

  With a vaccine still a long distance away, efforts to repurpose old medications used for other ailments provide hope of an early counter to COVID-19, say scientists, placing the antiviral remdesivir on top of the list of possible contenders.

• 

  Indian-origin scientist identifies four possible drugs to treat COVID-19

  World | May 05, 2020 15:57 IST

  An Indian-origin researcher in the US and his team have identified four antiviral drugs -- including remdesivir that was originally developed to treat Ebola -- which may be effective in inhibiting the replication of the novel coronavirus that causes COVID-19.

• 

  Zydus Cadila gets tentative nod from USFDA to market type-2 diabetes drug

  Science | May 02, 2020 14:21 IST

  Drug firm Zydus Cadila on Saturday said it has received tentative nod from the US health regulator to market generic Empagliflozin and Metformin Hydrochloride tablets, used for management of type-2 diabetes, in the American market

• 

  COVID-19 drug ready, proved to reduce duration of infection among patients: Strides Pharma

  Business | April 30, 2020 9:02 IST

  Officially called 'Favipiravir', the drug is believed to have proven to reduce the duration of coronavirus infection among patients. It has also resulted in the improvement of patients suffering from lung infections, Strides Pharma Science said. 

• 

  COVID-19 patients respond to Gilead's experimental drug remdesivir, says report

  World | April 17, 2020 16:59 IST

  Patients infected with the coronavirus are responding to remdesivir, an experimental drug of Gilead Sciences, news agency Reuters quoted a report as saying.

• 

  Hydroxychloroquine: Malaria drug, COVID-19 treatment. All you need to know

  Fyi | April 07, 2020 10:45 IST

  A report from China claimed Hydroxychloroquine helped more than 100 patients at 10 hospitals, but they had various degrees of illness and were treated with various doses for different lengths of time, and might have recovered without the drug.

• 

  Demand surges for 'game changer' coronavirus drug despite lack of clinical evidence

  India | April 03, 2020 16:49 IST

  The demand for hydroxychloroquine, a "game-changer" drug in the fight against COVID-19, is surging despite no clinical evidence of it being a cure against the disease.

• 

  Coronavirus Pandemic: 'New experimental drug may block entry of COVID-19 into human cells'

  Science | March 31, 2020 15:01 IST

  MIT scientists have designed a drug candidate that they say may block coronaviruses'' ability to enter human cells, an advance that could help develop a possible treatment for COVID-19.

• 

  Strides gets USFDA nod for anti-allergic drug

  Science | January 16, 2020 11:26 IST

  Strides Pharma Science on Thursday said it has received approval from the US health regulator for Loratadine Softgel Capsules, a medication typically used to treat allergies. In a filing to BSE Strides said its "step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, Singapore, has received approval for Loratadine Softgel Capsules, 10 mg (OTC) from the United States Food & Drug Administration (USFDA)."